Australia approves Sandoz's Omnitrope

The Australian Therapeutic Goods Administration (TGA) confirmed that it approved Sandoz's Omnitrope, a follow-on human growth hormone. The product is indicated for the long-term treatment of children above three

Read the full 290 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE